시장보고서

상품코드

1553660

금연 및 탈니코틴 중독 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 형태별, 유통 채널별, 지역별, 부문별 예측(2024-2030년)

Smoking Cessation And Nicotine De-addiction Market Size, Share & Trends Analysis Report By Type (Nicotine Replacement Therapy), By Form, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

발행일: 2024년 08월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

금연 및 탈니코틴 중독 시장 성장 및 동향 :

Grand View Research, Inc.의 조사 보고서에 따르면 세계 금연 및 니코틴 중독 시장 규모는 2030년까지 509억 달러에 달할 것으로 예상되며, 2024년부터 2030년까지 연평균 10.4%의 성장률을 나타낼 것으로 예상됩니다.

흡연 중독 인구는 전 세계적으로 빠르게 증가하고 있습니다. 이 인구층에는 주로 10대와 노동 인구가 포함됩니다. 흡연으로 인한 사망률은 매우 높습니다. 금연에 대한 열망과 흡연으로 인한 많은 건강 합병증은 흡연자의 금연을 돕는 차세대 니코틴 껌을 출시 한 레볼머와 같은 기업이 새로운 금연 제품을 출시하는 강력한 동기가되고 있습니다. 이러한 개선되고 혁신적인 니코틴 대체요법 제품의 출시는 금연 및 니코틴 의존증 치료제 시장의 성장에 큰 영향을 미치는 촉진제 역할을 할 것입니다.

만성폐쇄성폐질환(COPD), 천식, 심장질환, 폐암 등 대상 질환의 발병률 증가와 흡연의 유해한 부작용에 대한 인식 증가는 시장 확대를 촉진할 것으로 예상되는 요인입니다. 교육기관들은 흡연의 유해한 영향과 결과에 대한 정보를 전파하기 위해 다양한 캠페인과 프로그램을 적극적으로 실시하여 젊은 층의 인식을 제고하고 있습니다.

금연 및 탈니코틴 중독 시장 보고서 하이라이트

니코틴 대체요법(NRT)이 2023년 금연 및 탈니코틴 제품 시장을 장악했습니다. 주로 사용되는 NRT 제품에는 니코틴 껌과 경피 패치가 포함됩니다. 니코틴 껌과 경피 패치 등 다양한 맛의 니코틴 제품을 쉽게 구할 수 있게 된 것이 시장 점유율의 주요 요인으로 작용하고 있습니다.
전자 담배 분야는 예측 기간 동안 CAGR 8.48%로 성장할 것으로 예상됩니다. 전자 담배 시장 성장의 주요 요인은 2세대 및 3세대 전자 담배의 도입, 다양한 맛 제품의 가용성, 다양한 브랜드 이름으로 전자 담배를 운영 및 판매하는 수많은 공급업체의 존재 등입니다.
2023년 금연 및 탈니코틴 중독 시장은 북미가 40.3% 시장 점유율을 차지했습니다.
아시아태평양이 가장 빠르게 성장하고 있습니다. 중국, 인도, 호주와 같은 국가에서 니코틴 금연 제품 및 전자 담배가 등록되고 기업의 유통 채널이 강화되면서 예측 기간 동안 성장을 뒷받침합니다.
시장 기업들은 FDA 승인 니코틴 제품 시장 개발, 상품화 및 유통에 중점을 두어 전자 담배 시장에서 느리지만 꾸준히 발전하고 있습니다. 예를 들어, 2014년 Victory Electronic Cigarettes Corporation은 판매 채널을 확장하고 더 넓은 시장 범위를 확보하기 위해 Ten Motives Ltd.를 인수했습니다.

시장 서론/계통 전망
시장 규모와 성장 전망
시장 역학
- 시장 성장 촉진요인 분석
- 시장 성장 억제요인 분석
금연 및 탈니코틴 중독 시장 분석 툴
- Porter의 Five Forces 분석
- PESTEL 분석
- 정치 정세
- 경제와 사회 상황
- 기술적 상황
- 환경 상황
- 법적인 상황

제4장 금연 및 탈니코틴 중독 시장 : 유형별 추정·동향 분석

부문 대시보드
니코틴 대체요법
약물 요법
전자담배

제5장 금연 및 탈니코틴 중독 시장 : 형태 유형별 추정·동향 분석

부문 대시보드
금연 및 탈니코틴 중독 시장 : 형태 유형별 변동 분석, 2023년 및 2030년
껌
흡입기
태블릿
기타

제6장 금연 및 탈니코틴 중독 시장 : 유통 채널 유형별 추정·동향 분석

부문 대시보드
금연 및 탈니코틴 중독 시장 : 유통 채널 유형별 변동 분석, 2023년 & 2030년
병원 약국
온라인
드럭스토어 및 약국

제7장 금연 및 탈니코틴 중독 시장 : 지역별 추정·동향 분석

금연 및 탈니코틴 중독 시장 점유율, 지역별, 2023년 & 2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제8장 경쟁 구도

주요 시장 진출기업의 최근 동향과 영향 분석
기업 분류
기업 히트맵 분석
기업 개요
- Rusan Pharma Ltd
- Dr. Reddy's Laboratories Ltd
- Imperial Brands Plc
- Zydus Group.
- British American Tobacco Plc
- Perrigo Company Plc
- Johnson and Johnson Inc
- NJOY, LLC
- Cipla Ltd
- GlaxoSmithKline Plc.

LSH 24.09.26

Smoking Cessation And Nicotine De-addiction Market Growth & Trends:

The global smoking cessation and nicotine de-addiction market size is expected to reach USD 50.90 billion by 2030, growing at a CAGR of 10.4% from 2024 to 2030, according to a report by Grand View Research, Inc. The base of population addicted to smoking is rapidly increasing across the globe. This population subset majorly includes teenagers and the working population. Smoking-related mortality is very high. The increasing desire to quit smoking and the numerous health complications associated with smoking serve as strong incentives for companies to introduce novel smoking cessation products, such as Revolymer, which has introduced the next generation nicotine gums to help smokers quit smoking. The launch of these improved and innovative nicotine replacement therapy products is to serve as a high impact rendering driver for the growth of the smoking cessation and nicotine de-addiction market.

The growing incidence of target diseases such as chronic obstructive pulmonary disease (COPD), asthma, cardiac diseases, and lung cancer, and the increasing awareness pertaining to the hazardous side-effects of smoking are the factors expected to promote market expansion. Educational institutions remain active in organizing various campaigns and programs to spread information about the harmful effects and consequences of smoking so as to increase young population awareness.

Smoking Cessation And Nicotine De-addiction Market Report Highlights:

Nicotine Replacement Therapy (NRT) dominated the smoking cessation and de-nicotine addiction product market in 2023. Majorly used NRT products include nicotine chewing gums and the transdermal patches. Increased availability and the introduction of the ingestible nicotine products with different flavors are the factors responsible for its large market share.
The e-cigarette segment is anticipated to grow at a CAGR of 8.48% over the forecast period. The major factors responsible for the growth of the E-cigarette market include the introduction of second and third generation e-cigarettes, the availability of various flavored products, the presence of numerous vendors operating and selling e-cigarettes under different brand names.
North America dominated the smoking cessation and nicotine de-addiction market with a market share of 40.3% in 2023.
Asia Pacific is the fastest growing market. The registration of nicotine de-addiction products and e-cigarettes as well as the strengthening of the company distribution channels in countries, such as China, India, and Australia are expected to support the growth over the forecast period.
The market players are making slow but steady progress in the e-cigarette market by focusing on the development, commercialization, and distribution of the FDA approved nicotine products. For instance, in 2014, Victory Electronic Cigarettes Corporation acquired Ten Motives Ltd. with an aim to expand their distribution channels and attain wider market coverage.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Smoking Cessation and Nicotine De-addiction Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Smoking Cessation and Nicotine De-addiction Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1 Bargaining power of the suppliers
  - 3.4.1.2 Bargaining power of the buyers
  - 3.4.1.3 Threats of substitution
  - 3.4.1.4 Threats from new entrants
  - 3.4.1.5 Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.3 Political landscape
- 3.4.4 Economic and Social landscape
- 3.4.5 Technological landscape
- 3.4.6 Environmental landscape
- 3.4.7 Legal landscape

Chapter 4. Smoking Cessation and Nicotine De-addiction Market: Type Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Nicotine Replacement Therapy
- 4.2.1. Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.2.2 Nicotine Lozenges
  - 4.2.2.1 Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.2.3 Nicotine Gums
  - 4.2.3.1 Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.2.4 Nicotine Sprays
  - 4.2.4.1 Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.2.5 Nicotine Inhalers
4.3. Drug Therapy
- 4.3.1. Drug Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. E-cigarettes
- 4.4.1. E-cigarettes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Smoking Cessation and Nicotine De-addiction Market: Form Type Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Smoking Cessation and Nicotine De-addiction Market: Form Type Movement Analysis, 2023 & 2030 (USD Million)
5.3. Gum
- 5.3.1. Gum Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Inhalers
- 5.4.1. Inhalers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Tablets
- 5.5.1. Tablets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
- 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Smoking Cessation and Nicotine De-addiction Market: Distribution Channel Type Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Smoking Cessation and Nicotine De-addiction Market: Distribution Channel Type Movement Analysis, 2023 & 2030 (USD Million)
6.3. Hospital Pharmacies
- 6.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Online
- 6.4.1. Online Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Drug stores and Retail Pharmacies
- 6.5.1. Drug stores and Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Smoking Cessation and Nicotine De-addiction Market : Regional Estimates & Trend Analysis

7.1. Smoking Cessation and Nicotine De-addiction Market Share, By Region, 2023 & 2030 (USD Million)
7.2. North America
- 7.2.1. North America Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
  - 7.2.2.1 U.S. Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.3. Canada
  - 7.2.3.1 Canada Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.4. Mexico
  - 7.2.4.1 Mexico Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
- 7.3.1. Europe Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. UK
  - 7.3.2.1 UK Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Germany
  - 7.3.3.1 Germany Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. France
  - 7.3.4.1 France Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.5. Italy
  - 7.3.5.1 Italy Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.6. Spain
  - 7.3.6.1 Spain Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.7. Denmark
  - 7.3.7.1 Denmark Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.8. Sweden
  - 7.3.8.1 Sweden Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.9. Norway
  - 7.3.9.1 Norway Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
- 7.4.1. Asia Pacific Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. Japan
  - 7.4.2.1 Japan Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. China
  - 7.4.3.1 China Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. India
  - 7.4.4.1 India Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. Australia
  - 7.4.5.1 Australia Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. South Korea
  - 7.4.6.1 South Korea Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.7. Thailand
  - 7.4.7.1 Thailand Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
- 7.5.1. Latin America Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
  - 7.5.2.1 Brazil Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Argentina
  - 7.5.3.1 Argentina Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
- 7.6.1. Middle East and Africa Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. South Africa
  - 7.6.2.1 South Africa Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Saudi Arabia
  - 7.6.3.1 Saudi Arabia Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. UAE
  - 7.6.4.1 UAE Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Kuwait
  - 7.6.5.1 Kuwait Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
- 8.4.1. Rusan Pharma Ltd
  - 8.4.1.1 Participant's Overview
  - 8.4.1.2 Financial Performance
  - 8.4.1.3 Product Benchmarking
  - 8.4.1.4 Recent Developments/ Strategic Initiatives
- 8.4.2. Dr. Reddy's Laboratories Ltd
  - 8.4.2.1 Participant's Overview
  - 8.4.2.2 Financial Performance
  - 8.4.2.3 Product Benchmarking
  - 8.4.2.4 Recent Developments/ Strategic Initiatives
- 8.4.3. Imperial Brands Plc
  - 8.4.3.1 Participant's Overview
  - 8.4.3.2 Financial Performance
  - 8.4.3.3 Product Benchmarking
  - 8.4.3.4 Recent Developments/ Strategic Initiatives
- 8.4.4. Zydus Group.
  - 8.4.4.1 Participant's Overview
  - 8.4.4.2 Financial Performance
  - 8.4.4.3 Product Benchmarking
  - 8.4.4.4 Recent Developments/ Strategic Initiatives
- 8.4.5. British American Tobacco Plc
  - 8.4.5.1 Participant's Overview
  - 8.4.5.2 Financial Performance
  - 8.4.5.3 Product Benchmarking
  - 8.4.5.4 Recent Developments/ Strategic Initiatives
- 8.4.6. Perrigo Company Plc
  - 8.4.6.1 Participant's Overview
  - 8.4.6.2 Financial Performance
  - 8.4.6.3 Product Benchmarking
  - 8.4.6.4 Recent Developments/ Strategic Initiatives
- 8.4.7. Johnson and Johnson Inc
  - 8.4.7.1 Participant's Overview
  - 8.4.7.2 Financial Performance
  - 8.4.7.3 Product Benchmarking
  - 8.4.7.4 Recent Developments/ Strategic Initiatives
- 8.4.8. NJOY, LLC
  - 8.4.8.1 Participant's Overview
  - 8.4.8.2 Financial Performance
  - 8.4.8.3 Product Benchmarking
  - 8.4.8.4 Recent Developments/ Strategic Initiatives
- 8.4.9. Cipla Ltd
  - 8.4.9.1 Participant's Overview
  - 8.4.9.2 Financial Performance
  - 8.4.9.3 Product Benchmarking
  - 8.4.9.4 Recent Developments/ Strategic Initiatives
- 8.4.10. GlaxoSmithKline Plc.
  - 8.4.10.1 Participant's Overview
  - 8.4.10.2 Financial Performance
  - 8.4.10.3 Product Benchmarking
  - 8.4.10.4 Recent Developments/ Strategic Initiatives